Winners and Losers From the Biggest Cancer Meeting of the Year (So Far) [The Motley Fool]
ENDOCYTE (ECYT)
Last endocyte earnings: 11/7 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.endocyte.com/investor-relations
Company Research
Source: The Motley Fool
The meeting hasn't even started, and stocks are already moving. The American Society for Clinical Oncology (ASCO) annual meeting doesn't start for a few weeks, but a few companies made big moves on Thursday based on data in their abstracts that were released Wednesday evening. Here's a breakdown of the pops and drops and a look at what to expect when ASCO kicks off on June 1. Winner: Endocyte Endocyte 's ( NASDAQ:ECYT ) data from a phase 2 trial testing its prostate cancer drug 177Lu-PSMA-617 showed the drug could lower prostate-specific antigen (PSA), a marker for prostate cancer. Specifically, the drug reduced PSA by at least 50% in 62% of patients and by at least 80% in 44% of patients. Investors will have to wait for the meeting to get overall survival data, but presumably, it'll be solid enough because Endocyte has already committed to running a phase 3 trial for 177Lu-PSMA-617, which is scheduled to begin this quarter. Image source: Getty Images. Win
Show less
Read more
Impact Snapshot
Event Time:
ECYT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ECYT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ECYT alerts
High impacting ENDOCYTE news events
Weekly update
A roundup of the hottest topics